Protalix Biotherapeutics Inc (PLX)

CapEx to Revenue

2.98%

Quarterly · Period ending:

PLX logo

PLX CapEx to Revenue

Latest reported2.98%
PLX Quarterly CapEx/Revenue (0.00% → 2.98%)
High-resolution chart · PNG

PLX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Protalix Biotherapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
4.7757%
0%
0.2436%
1.5837%
3.1915%
1.0345%
145.6897%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.